Nitric oxide synthases: regulation and function
Open accessThe DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Abstract
Nitric oxide (NO), the smallest signalling molecule known, is produced by three isoforms of NO synthase (NOS; EC 1.14.13.39). They all utilize l-arginine and molecular oxygen as substrates and require the cofactors reduced nicotinamide-adenine-dinucleotide phosphate (NADPH), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), and (6R-)5,6,7,8-tetrahydrobiopterin (BH(4)). All NOS bind calmodulin and contain haem. Neuronal NOS (nNOS, NOS I) is constitutively expressed in central and peripheral neurons and some other cell types. Its functions include synaptic plasticity in the central nervous system (CNS), central regulation of blood pressure, smooth muscle relaxation, and vasodilatation via peripheral nitrergic nerves. Nitrergic nerves are of particular importance in the relaxation of corpus cavernosum and penile erection. Phosphodiesterase 5 inhibitors (sildenafil, vardenafil, and tadalafil) require at least a residual nNOS activity for their action. Inducible NOS (NOS II) can be expressed in many cell types in response to lipopolysaccharide, cytokines, or other agents. Inducible NOS generates large amounts of NO that have cytostatic effects on parasitic target cells. Inducible NOS contributes to the pathophysiology of inflammatory diseases and septic shock. Endothelial NOS (eNOS, NOS III) is mostly expressed in endothelial cells. It keeps blood vessels dilated, controls blood pressure, and has numerous other vasoprotective and anti-atherosclerotic effects. Many cardiovascular risk factors lead to oxidative stress, eNOS uncoupling, and endothelial dysfunction in the vasculature. Pharmacologically, vascular oxidative stress can be reduced and eNOS functionality restored with renin- and angiotensin-converting enzyme-inhibitors, with angiotensin receptor blockers, and with statins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This compensatory pathway may be particularly important for older adults”
From Dietary Nitrate-Rich Vegetables as Natural Modulators of Health: Mechanisms and Benefits in Ageing Populations (2026) · cites this paper as [244]
In the citing paper
“structural vascular changes (e.g., intimal thickening and reduced capillary density) can restrict NO signalling in advanced disease [168,244].”
From Dietary Nitrate-Rich Vegetables as Natural Modulators of Health: Mechanisms and Benefits in Ageing Populations (2026) · cites this paper as [244]
In the citing paper
“Superoxide reacts with NO to form peroxynitrite, thereby reducing NO bioavailability and impairing endothelial function [244].”
From Dietary Nitrate-Rich Vegetables as Natural Modulators of Health: Mechanisms and Benefits in Ageing Populations (2026) · cites this paper as [244]
In the citing paper
“The production of adequate levels of NO in the vascular endothelium is critical for the regulation of blood flow and vasodilation”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [299]
In the citing paper
“Among these isoforms, eNOS is the enzyme more abundant in vascular endothelial cells and has the most significant impact on vascular function, with a variety of pathologies related with eNOS dysfunction.”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [299]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
NITRIC OXIDE AND MACROPHAGE FUNCTION
MacMicking, J., Xie, Q.-W., & Nathan, C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.323 · Cited by 4,211
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110 · cited 1×
“However, a focus of the article will be on eNOS and functions of NO in the cardiovascular system. cofactor BH 4 , molecular oxygen, and the substrate L -arginine 14,15 ( Figure 2 ).”
BackgroundNitric oxide: an endogenous modulator of leukocyte adhesion.
Kubes, P., Suzuki, M., & Granger, D. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4651 · Cited by 3,029
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Self-citationLipton, S. A., Choi, Y.-B., Pan, Z.-H., Lei, S. Z., Chen, H.-S. V., Sucher, N. J., Loscalzo, J., Singel, D. J., & Stamler, J. S. (1993) · Nature · doi:10.1038/364626a0 · Cited by 2,433 · cited 1×
“46 Under those conditions, NO can contribute to excitotoxicity, probably via peroxynitrite activation of PARP and/or mitochondrial permeability transition.”
BackgroundGlutamate, nitric oxide and cell-cell signalling in the nervous system
Garthwaite, J. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90022-m · Cited by 2,402
Garg, U. C., & Hassid, A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114081 · Cited by 2,155
Research works printed but not linked: 10
- Hemmens, 1998, Methods in molecular biology (Clifton, N.J.), 100, 1
- 1984, Journal of cardiovascular pharmacology, 53, 557
- Izumi, 1993, Neuroreport, 4, 1131
- 1991, American Journal of Physiology -- Legacy Content, 260, G385
- Lefebvre, 2002, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgi , 64, 151
- Li, 1991, Cancer Research, 51, 2531
- Langrehr, 1991, Surgery, 110, 335
- 1990, 82, 113
- Li, 2000, The Journal of pathology, 190, 244, 10.1002/(sici)1096-9896(200002)190:3<244::aid-path575>3.0.co;2-8 · doi:10.1002/(sici)1096-9896(200002)190:3<244::aid-path575>3.0.co;2-8
- 2000, The Biochemical journal, 346, 767, 10.1042/0264-6021:3460767 · doi:10.1042/0264-6021:3460767
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
Excited-state intramolecular proton-transfer (ESIPT) based fluorescence sensors and imaging agents
Sedgwick, A. C., Wu, L., Han, H.-H., Bull, S. D., He, X.-P., James, T. D., Sessler, J. L., Tang, B. Z., Tian, H., & Yoon, J. (2018) · Chemical Society Reviews · doi:10.1039/c8cs00185e · Cited by 1,569
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Reperfusion injury and reactive oxygen species: The evolution of a concept
Granger, D. N., & Kvietys, P. R. (2015) · Redox Biology · doi:10.1016/j.redox.2015.08.020 · Cited by 1,484
Metadata
- Authors
- Forstermann, U., & Sessa, W. C.
- Affiliations
- Yale University (US)
- ORCID
- Sessa, W. C.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-09-01
- Volume
- 33
- Issue
- 7
- Pages
- 829-837
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC3345541
- OpenAlex
- W1997023449
- Cited by
- 4,409
- References
- 177
- Citations by year
- 2026: 337 · 2025: 402 · 2024: 364 · 2023: 400 · 2022: 364 · 2021: 432 · 2020: 386 · 2019: 346 · 2018: 309 · 2017: 285 · 2016: 204 · 2015: 208 · 2014: 190 · 2013: 109 · 2012: 61
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (LI-1042/1-1)
- Bundesministerium für Bildung und Forschung
- National Institutes of Health (P01 HL70295, HL61371, R01 HL61371)
- National Heart, Lung, and Blood Institute (P01HL070295, R01HL096670, R01HL064793, R01-HL61371, P01 HL70295, R01HL081190, R01 HL64793, R01HL061371)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- nitric oxide synthase, nitric oxide, neuronal NOS, inducible nitric oxide synthase, endothelial NOS, NOS isoforms, calmodulin, tetrahydrobiopterin, nitrergic neurons, synaptic plasticity, blood pressure regulation, vasodilation, phosphodiesterase-5 inhibitors, penile erection, endothelial dysfunction, oxidative stress, septic shock, inflammation, ACE inhibitors, statins, angiotensin receptor blockers
- MeSH terms
- Animals, Arginine, Biopterins, Cardiovascular Agents, Cardiovascular Diseases, Endothelium, Vascular, Humans, Isoenzymes, Nitric Oxide, Genetic Therapy, Neovascularization, Physiologic, Nitric Oxide Synthase, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Mice, Nitric Oxide Synthase Type II, Nitric Oxide Synthase Type I, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nitric oxide synthases: regulation and function. https://app.cochat.ai/papers/10.1093/eurheartj/ehr304
- The paper
- Forstermann, U., & Sessa, W. C. (2012). Nitric oxide synthases: regulation and function. European Heart Journal. https://doi.org/10.1093/eurheartj/ehr304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.